Making Medical Discoveries for Humanity

Total Page:16

File Type:pdf, Size:1020Kb

Making Medical Discoveries for Humanity ADVERTISEMENT FEATURE MAKING MEDICAL DISCOVERIES FOR HUMANITY A supportive environment and access to superb facilities pave the way for researchers to have a major impact in the search for treatments. teams to develop new structural biologist changes from an inactive form to approaches to preventing and Dr Peter Czabotar (pictured). an active, pro-apoptotic form. treating diseases. The institute His research focuses on proteins “Knowing what was focuses on three critical areas: that control apoptotic cell death, happening to the proteins gave cancer, including blood, breast, the process which determines us a new way of understanding brain, gastrointestinal and rare the number of cells in the body. how they induce cell death,” Dr cancers; immune disorders, “Dysregulated apoptosis has Czabotar says. He comments including asthma, coeliac been implicated in a range of that the focus on translating disease, diabetes and lupus; and diseases, including cancer, research into clinical outcomes infectious diseases, particularly autoimmune diseases and was a highlight of working at malaria, hepatitis B and HIV. neurodegenerative conditions,” the institute. The Walter and Eliza Hall Institute scientists he explains. “For example, in “One exciting field has been Institute (WEHI) is a world- have access to a range of some cancers, disruptions in the development of compounds class medical research institute technologies including high- normal apoptotic cell death that block pro-survival proteins, located in Melbourne’s Parkville throughput screening, genomics enable cancer cells to survive which may have applications biomedical hub. More than and gene editing, proteomics when they should die.” for treating cancers or 800 researchers at the institute and microscopy. The strong Part of Dr Czabotar’s research other conditions,” he says. strive for breakthroughs to be collaborative culture gives considers molecular changes “Engineering new compounds translated into better treatments researchers access to additional in BAX, a protein that drives that prevent cell death could for improved health around infrastructure, such as the cell death. The Australian also revolutionize the treatment the world. Australian Synchrotron. Synchrotron enabled his team to of other diseases.” Its scientists work in The synchrotron was critical create three-dimensional images In addition to its collaborative, multidisciplinary to recent discoveries by institute of BAX to understand how it international reputation for fundamental and translational research, the institute strongly advocates for gender TOP 10 COLLABORATORS (2016 FC) BY NUMBERS 1. The University of Melbourne (UniMelb) 19.79 equity and has implemented 2. Monash University 4.69 initiatives to build diversity in 3. La Trobe University 3.46 4. Vienna Biocenter (VBC), Austria 2.62 its workforce. Many exciting 5. Melbourne Health 2.05 TOP RANKED NON-PROFIT 6. Peter MacCallum Cancer Centre (Peter Mac) 1.65 opportunities for research ORGANIZATION INSTITUTION 7. Case Western Reserve University (CWRU) 1.59 faculty, postdoctoral research IN AUSTRALIA EVERY YEAR 8. Imperial College London (ICL) 1.44 FROM 2012 TO 2016 9. University of New South Wales (UNSW) 1.13 and study are available at the # (ALL SUBJECTS, WFC) 10. The University of Sydney (USYD), Australia 1.05 institute: www.wehi.edu.au/ 1 n about/career-opportunities. NUMBER OF DOMESTIC AND INTERNATIONAL 8 COLLABORATING 7 4 INSTITUTIONS 2016* 40 domestic 10 331 international 1 9 *excludes joint institutions 2 6 www.wehi.edu.au WFC = weighted fractional count 3 5 +61 3 9345 2555 [email protected] Source: Nature Index Advertiser retains sole responsibility for content.
Recommended publications
  • 2010-2011 Annual Report
    Annual Report 2010-2011 Mastery of disease through discovery | www.wehi.edu.au Contents 1 About the institute 3 Director’s and Chairman’s report 5 Discovery 8 Cancer and Haematology 10 Stem Cells and Cancer 12 Molecular Genetics of Cancer 14 Chemical Biology 16 Molecular Medicine 18 Structural Biology 20 Bioinformatics 22 Infection and Immunity 24 Immunology The Walter and Eliza Hall Institute 26 Autoimmunity and Transplantation of Medical Research 28 Cell Signalling and Cell Death 1G Royal Parade 30 Inflammation Parkville Victoria 3052 Australia Telephone: (+61 3) 9345 2555 32 Molecular Immunology Facsimile: (+61 3) 9347 0852 34 Publications WEHI Biotechnology Centre 36 Awards 4 Research Avenue 37 Translation La Trobe R&D Park Bundoora Victoria 3086 Australia Translating our research 38 Telephone: (+61 3) 9345 2200 40 Developing our research Facsimile: (+61 3) 9345 2211 42 Patents www.wehi.edu.au www.facebook.com/WEHIresearch 43 Education www.twitter.com/WEHI_research 46 2010-11 graduates ABN 12 004 251 423 47 Seminars Acknowledgements 48 Institute awards Produced by the institute’s Community Relations department 49 Engagement Managing editor: Penny Fannin Editor: Liz Williams 51 Strategic partners Writers: Liz Williams, Vanessa Solomon and Julie Tester 52 Scientific and medical community Design and production: Simon Taplin Photography: Czesia Markiewicz and Cameron Wells 54 Public engagement 57 Engagement with schools Cover image 58 Donor and bequestor engagement Art in Science finalist 2010 Vessel webs 59 Sustainability Dr Leigh Coultas, Cancer and Haematology division 60 The Board This image shows the delicate intricacy in the developing eye of a transient population of web-like blood vessels.
    [Show full text]
  • VLSCI Is Funded by the Victorian Government and Contributing Institutions and Is Hosted by the University of Melbourne
    VLSCI is funded by the Victorian Government and contributing institutions and is hosted by the University of Melbourne. This petascale facility delivers expertise and systems for life sciences computing. From 2010-2014 the first ever IBM Research Collaboratory for Life Sciences was co-located at VLSCI. CONTENTS EXECUTIVE REPORTS 06. AustrALIAN HPC AT SupercoMPUTING Steering Committee Chair’s Report ................. 6 2014 ................................................................... 52 Scientific Advisory Committee Chair’s Report 8 Director’s Report ................................................. 9 07. INTERActioNS ................................................ 54 In the news ........................................................ 58 01. VLSCI NOW ....................................................... 12 Industry Engagement....................................... 60 About the VLSCI................................................ 13 Our People ........................................................ 14 08. CAREER DevelopMENT FOR COMPUTATIONAL BioloGists .................... 62 02. 2014 SNAPSHots ........................................... 16 PhD Top-Ups, Summer Internships, UROP .... 64 Research Impact ............................................... 17 Internships 2013-2014 ..................................... 68 Collaborations ................................................... 20 Skills Development ........................................... 69 Martin Krzywinski Melbourne Tour ................. 22 MSc (Bioinformatics) Graduates
    [Show full text]
  • Mount Morgan
    75 AN OLD MINING TOWN IN QUEENSLAND : MOUNT MORGAN by F. L. GOLDING, A.A.S.A. Delivered on behalf of the Mount Morgan and District Historical Society at Newstead, Brisbane, on 25 May 1978 On 27 May 1948 the late Benjamin Gilmour Patterson, B.E., M.A.I.M.M. (then chief surveyor of the Cential Queensland min­ ing company — Mount Morgan Ltd.) delivered a paper to the Historical Society of Queensland — and his subject was The Story of the Discovery of Mount Morgan. An excellent paper which was issued in book form by the Brisbane printing firm of W. R. Smith and Paterson Pty. Ltd. Now here 1 am, almost 30 years later to the night t© deliver another paper on Mount Morgan to the same Historical Society (although it is now honoured with the title 'Royal'). Mr. Patterson's lecture was all about our famous mine; I will be talking more about the town itself — its people, institutions and buildings. However, if there wasn't any mine there wouldn't have been any town, so it will be necessary to bring in some information about the mine as an introduction for the main sub­ ject of this paper. It seems to be an accepted fact that the very first white man to pass by and probably look at "Ironestone Mountain" (the name of the place before the Morgan brothers gave it their name) were Charles and William Archer on their journey up the Dee River Valley in 1853. They had been told about the Fitzroy River by that well-known and famous explorer Dr.
    [Show full text]
  • Fannie Eleanor Williams: Bacteriologist and Serologist
    Fannie Eleanor Williams: Bacteriologist and Serologist Kirsty Harris School of Historical and Philosophical Studies University of Melbourne, Parkville, VIC. 3010 [email protected] Abstract: This chapter reveals the vital role of Fannie Eleanor Williams in the field of medical science in Australia. It argues that Williams, as a bacteriologist and serologist from the early days in Adelaide to her long career at the Walter and Eliza Hall Institute, Melbourne, should be more highly recognised as a leader in her research, laboratory management and mentoring. Although her contribution to medical science has been undervalued, she was the first female to undertake some of her activities and in doing so led the way for other women. This leadership role has been made invisible as a result of historians’ patriarchal presumptions about women’s roles and work. The chapter rectifies some of the misconceptions within the historiography of Australian science that have obscured Williams’ leadership. Keywords: Walter and Eliza Hall Institute, bacteriology, blood transfusion service, serology, women in science, medical research In 2011, the newly appointed CEO of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne made a public call for more women to become leaders in medical science. Yet there was no reference to the institute’s very own first female medical scientist, Fannie Eleanor Williams. Over the past half century, the profile and contribution of Williams has suffered under the hands of institute men, academics and historians – being labelled as just a nurse, technician and even housekeeper rather than the professional bacteriologist, serologist and leader that she was.
    [Show full text]
  • December 2014.Indd
    NEWSLETTER PP 100000910 ISSN 1442-8725 December 2014 Clinical and Translational Immunology: A new platform to publish your research Gabrielle Belz* and Rajiv Khanna¶ *Editor-in-Chief, Clinical & Translational Immunology, Walter and Eliza Hall Institute, Melbourne, Vic. ¶Deputy Editor, Clinical & Translational Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Qld. Clinical & Translational Immunology diseases. We have also published solicited effi cacy in the treatment of malignant is a joint initiative of The Australasian reviews on timely topics in basic/clinical melanoma. However, IL-21 therapy can Society for Immunology (ASI) and Nature immunology. In addition, we also publish rapidly and potently induce natural killer Publishing Group (NPG). This journal is an ground-breaking case reports and letters to and cytotoxic T cell activation in patients, open access journal and is a companion title the editor. implying that this cytokine may yet be to Immunology & Cell Biology (published useful in stimulating the immune response by NPG in partnership with the ASI). The All content published in Clinical & to cancers. Dale Godfrey and Jonathan changing landscape of the immunology Translational Immunology is open access Coquet, now at the Flemish Institute of fi eld has resulted in an increasing focus and is freely available to researchers Biotechnology in Ghent, Belgium, and his on excellent clinical immunology and worldwide through the nature.com platform. colleagues now report that IL-21 therapy translational research, with a corresponding We are delighted to announce Clinical & in patients with malignant melanoma increase in submissions on these topics. Translational Immunology was recently modulates the function of NKT cells, a The pioneering work undertaken by many accepted in to PubMed Central.
    [Show full text]
  • 2011-2012 Annual Report 2011-2012 2 Walter and Eliza Hall Institute Annual Report 2011-2012 Supplementary Information Director’S and Chairman’S Report
    Annual Report 2011-2012 Supplementary information Contents 1 About the institute 99 Engagement 3 Director’s and Chairman’s report 101 Strategic partners 5 Discovery 102 Scientific and medical community 8 Cancer and Haematology 104 Public engagement 12 ACRF Stem Cells and Cancer 107 Donor and bequestor engagement 16 Molecular Genetics of Cancer 109 Service to the scientific and wider community 20 ACRF Chemical Biology 118 Sustainability 24 Molecular Medicine 119 The Board 28 Structural Biology 123 Chief Operating Officer’s report 32 Bioinformatics 126 Supporters and donors 36 Infection and Immunity 131 Institute organisation 40 Immunology 132 Members of the institute 44 Cell Signalling and Cell Death 133 Staff list 48 Inflammation 136 Committees 52 Molecular Immunology 140 The year at a glance 56 Systems Biology and Personalised Medicine 141 Financial statements 59 Publications 168 Statistical summary 74 Awards 169 Capital Funds 75 Translation 76 Translating our research 78 Developing our research 80 Patents granted in 2011-2012 81 Education 84 2011-12 graduates 85 2011-12 PhD in progress 88 Bachelor of Science (Honours) in progress 89 2011-12 vacation scholars 90 Seminars 91 2011-12 institute speakers 93 2011-12 visiting speakers 96 2012 postgraduate lecture series 98 Institute awards Walter and Eliza Hall Institute Annual Report 2011-2012 Supplementary information Annual Report 2011-2012 Supplementary information CANCER | CHRONIC INFLAMMATORY DISEASE | INFECTIOUS DISEASE Walter and Eliza Hall Institute Annual Report 2011-2012 Supplementary
    [Show full text]